|
1
|
Spira A and Ettinger DS: Multidisciplinary
management of lung cancer. N Engl J Med. 350:379–392. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Quint LE, Tummala S, Brisson LJ, Francis
IR, Krupnick AS, Kazerooni EA, Iannettoni MD, Whyte RI and Orringer
MB: Distribution of distant metastases from newly diagnosed
non-small cell lung cancer. Ann Thorac Surg. 62:246–250. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han L, Liang XH, Chen LX, Bao SM and Yan
ZQ: SIRT1 is highly expressed in brain metastasis tissues of
non-small cell lung cancer (NSCLC) and in positive regulation of
NSCLC cell migration. Int J Clin Exp Pathol. 6:2357–2365.
2013.PubMed/NCBI
|
|
4
|
Barnholtz-Sloan JS, Sloan AE, Davis FG,
Vigneau FD, Lai P and Sawaya RE: Incidence proportions of brain
metastases in patients diagnosed (1973 to 2001) in the Metropolitan
Detroit Cancer Surveillance System. J Clin Oncol. 22:2865–2872.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stuschke M, Eberhardt W, Pöttgen C,
Stamatis G, Wilke H, Stüben G, Stöblen F, Wilhelm HH, Menker H,
Teschler H, et al: Prophylactic cranial irradiation in locally
advanced non-small-cell lung cancer after multimodality treatment:
Long-term follow-up and investigations of late neuropsychologic
effects. J Clin Oncol. 17:2700–2709. 1999.PubMed/NCBI
|
|
6
|
Wang SY, Ye X, Ou W, Lin YB, Zhang BB and
Yang H: Risk of cerebral metastases for postoperative locally
advanced non-small-cell lung cancer. Lung Cancer. 64:238–243. 2009.
View Article : Google Scholar
|
|
7
|
Eberhardt W, Wilke H, Stamatis G, Stuschke
M, Harstrick A, Menker H, Krause B, Müeller MR, Stahl M, Flasshove
M, et al: Preoperative chemotherapy followed by concurrent
chemoradiation therapy based on hyperfractionated accelerated
radiotherapy and definitive surgery in locally advanced
non-small-cell lung cancer: Mature results of a phase II trial. J
Clin Oncol. 16:622–634. 1998.PubMed/NCBI
|
|
8
|
Knisely JP, Berkey B, Chakravarti A, Yung
AW, Curran WJ Jr, Robins HI, Movsas B, Brachman DG, Henderson RH
and Mehta MP: A phase III study of conventional radiation therapy
plus thalidomide versus conventional radiation therapy for multiple
brain metastases (RTOG 0118). Int J Radiat Oncol Biol Phys.
71:79–86. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fidler IJ: The role of the organ
microenvironment in brain metastasis. Semin Cancer Biol.
21:107–112. 2011. View Article : Google Scholar
|
|
10
|
Zhao C, Xu Y, Zhang Y, Tan W, Xue J, Yang
Z, Zhang Y, Lu Y and Hu X: Downregulation of miR-145 contributes to
lung adenocarcinoma cell growth to form brain metastases. Oncol
Rep. 30:2027–2034. 2013.PubMed/NCBI
|
|
11
|
Cavallaro S: CXCR4/CXCL12 in
non-small-cell lung cancer metastasis to the brain. Int J Mol Sci.
14:1713–1727. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vogetseder A, Thies S, Ingold B, Roth P,
Weller M, Schraml P, Goodman SL and Moch H: αv-Integrin isoform
expression in primary human tumors and brain metastases. Int J
Cancer. 133:2362–2371. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pang X, Min J, Liu L, Liu Y, Ma N and
Zhang H: S100B protein as a possible participant in the brain
metastasis of NSCLC. Med Oncol. 29:2626–2632. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rojiani MV, Alidina J, Esposito N and
Rojiani AM: Expression of MMP-2 correlates with increased
angiogenesis in CNS metastasis of lung carcinoma. Int J Clin Exp
Pathol. 3:775–781. 2010.PubMed/NCBI
|
|
15
|
Preusser M, Berghoff AS, Berger W,
Ilhan-Mutlu A, Dinhof C, Widhalm G, Dieckmann K, Wöhrer A, Hackl M,
von Deimling A, et al: High rate of FGFR1 amplifications in brain
metastases of squamous and non-squamous lung cancer. Lung Cancer.
83:83–89. 2014. View Article : Google Scholar
|
|
16
|
Lee HW, Seol HJ, Choi YL, Ju HJ, Joo KM,
Ko YH, Lee JI and Nam DH: Genomic copy number alterations
associated with the early brain metastasis of non-small cell lung
cancer. Int J Oncol. 41:2013–2020. 2012.PubMed/NCBI
|
|
17
|
Olshen AB, Venkatraman ES, Lucito R and
Wigler M: Circular binary segmentation for the analysis of
array-based DNA copy number data. Biostatistics. 5:557–572. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Venkatraman ES and Olshen AB: A faster
circular binary segmentation algorithm for the analysis of array
CGH data. Bioinformatics. 23:657–663. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Krzywinski M, Schein J, Birol I, Connors
J, Gascoyne R, Horsman D, Jones SJ and Marra MA: Circos: An
information aesthetic for comparative genomics. Genome Res.
19:1639–1645. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J R Stat Soc Series. 57:289–300. 1995.
|
|
21
|
Casorzo L, Corigliano M, Ferrero P,
Venesio T and Risio M: Evaluation of 7q31 region improves the
accuracy of EGFR FISH assay in non small cell lung cancer. Diagn
Pathol. 4:362009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wrage M, Ruosaari S, Eijk PP, Kaifi JT,
Hollmén J, Yekebas EF, Izbicki JR, Brakenhoff RH, Streichert T,
Riethdorf S, et al: Genomic profiles associated with early
micrometastasis in lung cancer: Relevance of 4q deletion. Clin
Cancer Res. 15:1566–1574. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee HJ, Song IC, Yun HJ, Jo DY and Kim S:
CXC chemokines and chemokine receptors in gastric cancer: From
basic findings towards therapeutic targeting. World J
Gastroenterol. 20:1681–1693. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sarvaiya PJ, Guo D, Ulasov I, Gabikian P
and Lesniak MS: Chemokines in tumor progression and metastasis.
Oncotarget. 4:2171–2185. 2013.PubMed/NCBI
|
|
25
|
He G, Zhang B, Zhang B, Qiao L, Tian Z,
Zhai G, Xin X, Yang C, Liu P, Zhang Y, et al: Th17 cells and IL-17
are increased in patients with brain metastases from the primary
lung cancer. Zhongguo Fei Ai Za Zhi. 16:476–481. 2013.In Chinese.
PubMed/NCBI
|
|
26
|
Gilkes DM, Semenza GL and Wirtz D: Hypoxia
and the extracellular matrix: Drivers of tumour metastasis. Nat Rev
Cancer. 14:430–439. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schroder WA, Major LD, Le TT, Gardner J,
Sweet MJ, Janciauskiene S and Suhrbier A: Tumor cell-expressed
SerpinB2 is present on microparticles and inhibits metastasis.
Cancer Med. 3:500–513. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Grinberg-Rashi H, Ofek E, Perelman M,
Skarda J, Yaron P, Hajdúch M, Jacob-Hirsch J, Amariglio N, Krupsky
M, Simansky DA, et al: The expression of three genes in primary
non-small cell lung cancer is associated with metastatic spread to
the brain. Clin Cancer Res. 15:1755–1761. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hong LZ, Wei XW, Chen JF and Shi Y:
Overexpression of periostin predicts poor prognosis in non-small
cell lung cancer. Oncol Lett. 6:1595–1603. 2013.PubMed/NCBI
|
|
30
|
Su LK, Vogelstein B and Kinzler KW:
Association of the APC tumor suppressor protein with catenins.
Science. 262:1734–1737. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chu EC and Tarnawski AS: PTEN regulatory
functions in tumor suppression and cell biology. Med Sci Monit.
10:RA235–RA241. 2004.PubMed/NCBI
|
|
32
|
Pećina-Šlaus N, Nikuševa Martić T, Zeljko
M and Bulat S: Brain metastases exhibit gross deletions of the APC
gene. Brain Tumor Pathol. 28:223–228. 2011. View Article : Google Scholar
|
|
33
|
Fidler MJ, Morrison LE, Basu S, Buckingham
L, Walters K, Batus M, Jacobson KK, Jewell SS, Coon J IV and Bonomi
PD: PTEN and PIK3CA gene copy numbers and poor outcomes in
non-small cell lung cancer patients with gefitinib therapy. Br J
Cancer. 105:1920–1926. 2011. View Article : Google Scholar : PubMed/NCBI
|
